Ginkgo Bioworks Rockefeller Foundation Funds Global Pathogen Sequencing With $20M, Forms Collaborations The funding and alliances mark the first step in the foundation's establishment of a pandemic prevention institute, which will collaborate with similar efforts elsewhere. Ginkgo Bioworks Acquires Dutch DNA Biotech The news comes less than a week after Ginkgo announced its plan to merge with SPAC Soaring Eagle Acquisition in order to go public. Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium The firm also exercised "buy down" rights to two workflows developed with Ginkgo Bioworks and announced changes to its board of directors. Ginkgo Bioworks Going Public Through Merger With SPAC The deal, which is expected to close in the third quarter of this year, implies a $15 billion pre-money equity valuation for Ginkgo. Ginkgo Bioworks, Olive Labs, CQuentia to Provide SARS-CoV-2 Pooled Testing in K-12 Schools Concentric by Ginkgo has been partnering with labs across the US in more than 15 states to run testing for schools offering in-person education. Mar 26, 2021 Dascena Labs, Ginkgo Bioworks Partner to Scale Pooled SARS-CoV-2 Testing in Schools Dec 10, 2020 Ginkgo Bioworks, Octant to Establish Bay Area Coronavirus Test Processing Facility Nov 25, 2020 In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More Oct 5, 2020 Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells Premium Aug 7, 2020 Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes Premium Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics May 28, 2020 Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing May 12, 2020 High-Throughput Diagnostic COVID-19 Sequencing Assays May Enable Large-Scale Testing Premium Jan 22, 2020 M&A Deals in MDx/Omics Research Tools Space Up 13 Percent in 2019 Premium Oct 10, 2019 Ginkgo Bioworks Launches $350M Funding Vehicle for Spinoffs Oct 1, 2019 Ginkgo Bioworks, Berkeley Lights Strike $150M Synthetic Biology Deal Breaking News MERS-Related Coronavirus Among Viruses Found in Swiss Bat Screening Study Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.